Methyl 2-amino-4-(2-methoxy-2-oxoethyl)thiazole-5-carboxylate hydrochloride, 97.0%, 1g

2,3-Dihydroxynaphthalene>98.0%(GC)(T)250g

4-Bromo-2-(tert-butyl)pyridine, 95.0%, 250mg

(5-Methyl-4H-1,2,4-triazol-3-yl)methanamine hydrochloride, 97%, 5g

5-Cyclopropyl-3-iodo-1H-pyrazole, 95.0%, 1g

4-BROMO-6-INDAZOLECARBOXYLIC ACID METHYL ESTER, 95%, 1g

GC capillary column ROTI®Cap-5, 10 m, 0.53 mm, 0.50 µm, 1 Piece(s)

Methyl fluorosulfonyldifluoroacetate, 97.0%, 5g

(R)-1-(2-Methylbenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

(3-Trifluoromethyl-5,6,7,8-tetrahydro-4 H -cycloheptapyrazol-1-yl)-acetic acid, 95.0%, 1g

tert-Butyl 4-(4-fluoro-2-nitrophenyl)piperazine-1-carboxylate, 95.0%, 1g

(2-(3-Bromophenyl)ethene-1,1,2-triyl)tribenzene, 98%, 1g

1-Bromodecane>98.0%(GC)500mL